349 related articles for article (PubMed ID: 18582492)
1. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
2. Effects of norketamine enantiomers in rodent models of persistent pain.
Holtman JR; Crooks PA; Johnson-Hardy JK; Hojomat M; Kleven M; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):676-85. PubMed ID: 18586315
[TBL] [Abstract][Full Text] [Related]
3. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
[TBL] [Abstract][Full Text] [Related]
4. Interactions of (2S,6S;2R,6R)-Hydroxynorketamine, a Secondary Metabolite of (R,S)-Ketamine, with Morphine.
Lilius TO; Viisanen H; Jokinen V; Niemi M; Kalso EA; Rauhala PV
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):481-488. PubMed ID: 29171155
[TBL] [Abstract][Full Text] [Related]
5. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
[TBL] [Abstract][Full Text] [Related]
6. Ketamine and norketamine attenuate oxycodone tolerance markedly less than that of morphine: from behaviour to drug availability.
Lilius T; Kangas E; Niemi M; Rauhala P; Kalso E
Br J Anaesth; 2018 Apr; 120(4):818-826. PubMed ID: 29576122
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutamic acid and ketamine on morphine-induced analgesic response in rats.
Suman P; Talwar A; Tandon OP
Indian J Physiol Pharmacol; 2000 Jan; 44(1):33-42. PubMed ID: 10919093
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
10. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats.
Joó G; Horvath G; Klimscha W; Kekesi G; Dobos I; Szikszay M; Benedek G
Anesthesiology; 2000 Jul; 93(1):231-41. PubMed ID: 10861167
[TBL] [Abstract][Full Text] [Related]
11. Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat.
Lilius TO; Jokinen V; Neuvonen MS; Niemi M; Kalso EA; Rauhala PV
Br J Pharmacol; 2015 Jun; 172(11):2799-813. PubMed ID: 25297798
[TBL] [Abstract][Full Text] [Related]
12. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.
Malec D; Mandryk M; Fidecka S
Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375
[TBL] [Abstract][Full Text] [Related]
13. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological response properties of medullary pain-control neurons following chronic treatment with morphine or oxycodone: modulation by acute ketamine.
Viisanen H; Lilius TO; Sagalajev B; Rauhala P; Kalso E; Pertovaara A
J Neurophysiol; 2020 Sep; 124(3):790-801. PubMed ID: 32755331
[TBL] [Abstract][Full Text] [Related]
15. Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast.
Lilius TO; Rauhala PV; Kambur O; Kalso EA
Anesthesiology; 2009 Dec; 111(6):1356-64. PubMed ID: 19934882
[TBL] [Abstract][Full Text] [Related]
16. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
17. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
[TBL] [Abstract][Full Text] [Related]
18. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
Bulka A; Wiesenfeld-Hallin Z; Xu XJ
Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of MK-801 and morphine attenuates neuropathic pain in rat.
Hamidi GA; Manaheji H; Janahmadi M; Noorbakhsh SM; Salami M
Physiol Behav; 2006 Jul; 88(4-5):628-35. PubMed ID: 16815501
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
